Abbott Laboratories: Why I Agree With Wall Street On This One


  • Wall Street analysts have a ‘strong buy’ rating on ABT stock, with 12 out of 24 analysts giving it this rating in the last 90 days.
  • We agree with such bullish sentiment.
  • Despite some risks, ABT stock has the potential to outperform the overall market by a large margin.
  • The key return drivers include its strong growth potential, high ROCE, and a discounted valuation.

Abbott Laboratories headquarters in Silicon Valley

Sundry Photography

ABT stock: Wall Street loves it

Readers following our writing know that we are contrarian investors and we usually bet against Wall Street ratings. However, in the case of Abbott Laboratories (NYSE:ABT) stock, we found ourselves in agreement

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Join Envision Early Retirement to navigate such a turbulent market.

  • Receive our best ideas, actionable and unambiguous, across multiple assets.
  • Access our real-money portfolios, trade alerts, and transparent performance reporting.
  • Use our proprietary allocation strategies to isolate and control risks.

We have helped our members beat S&P 500 with LOWER drawdowns despite the extreme volatilities in both the equity AND bond market.

Join for a 100% Risk-Free trial and see if our proven method can help you too. You do not need to pay for the costly lessons from the market itself.

Leave a Reply

Your email address will not be published. Required fields are marked *